SEARCH

SEARCH BY CITATION

References

  • 1
    Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329:18421847. MEDLINE
  • 2
    Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease. Hepatology 1991; 13:619626. MEDLINE
  • 3
    O'Grady JG, Smith HM, Davies S, Daniels HM, Donaldson PT, Tan KC, et al. Hepatitis B virus re-infection after liver transplantation: Serological and clinical implications. J Hepatol 1992; 14:104111. MEDLINE
  • 4
    König V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, et al. Long-term follow-up of hepatitis B virus–infected recipients after orthotopic liver transplantation. Transplantation 1994; 58:553559. MEDLINE
  • 5
    Davies S, Portmann B, O'Grady J, Aldis P, Chaggar K, Alexander G, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13:150157. MEDLINE
  • 6
    Lau JYN, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJM, et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102:956962. MEDLINE
  • 7
    Tur-Kaspa R, Laub O. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol 1990; 11:3436. MEDLINE
  • 8
    Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H. Retransplantation in hepatitis B—A multicenter experience. Transplantation 1994; 57:823826. MEDLINE
  • 9
    Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24:13271333. MEDLINE
  • 10
    Lake JR. Should liver transplantation be performed for patients with chronic hepatitis B? Yes! Liver Transpl Surg 1995; 1:260265. MEDLINE
  • 11
    Kiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, et al. Prevention of hepatitis B “rerecurrence” after a second liver transplant—The role of maintenance polyclonal HBIg therapy. Transplantation 1994; 58:954956. MEDLINE
  • 12
    Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, et al. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation 1997; 64:410414. MEDLINE
  • 13
    McGory RW, Ishitani M, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364. MEDLINE
  • 14
    Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23:17. MEDLINE
  • 15
    Krüger M, Tillmann HL, Trautwein C, Bode U, Oldhafer K, Maschek H, et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study. Liver Transpl Surg 1996; 2:253262. MEDLINE
  • 16
    Haller GW, Bechstein WO, Platz KP, Neuhaus R, Hopf U, Neuhaus P. Treatment of recurrent hepatitis B infection after liver transplantation with famciclovir [abstr]. J Hepatol 1995; 23:152.
  • 17
    Bain VG, Kneteman NM, Ma MM, Gutfreund K, Shapiro JA, Fischer K, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Tranplantation 1996; 62:14561462.
  • 18
    Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, et al. Lamivudine prophylaxis against re-infection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:12121215. MEDLINE
  • 19
    Gugenheim J, Samuel D, Saliba F, Castaing D, Bismuth H. Use of flexible triple-drug immunosuppressive therapy in liver transplantation. Transplant Proc 1987; 19:38053807. MEDLINE
  • 20
    Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. the METAVIR Cooperative Study Group. Hepatology 1996; 24:289293. MEDLINE
  • 21
    Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337:813815. MEDLINE
  • 22
    Gugenheim J, Crafa F, Fabiani P, Goubaux B, Ouzan D, Mouiel J. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in Hbs antigen–positive patients. Transplant Proc 1993; 25:13491350. MEDLINE
  • 23
    Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C. Liver transplantation in Hbs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13:9096. MEDLINE
  • 24
    Mora N, Klintmalm G, Poplawski S, Cofer J, Husberg B, Gonwa TA, et al. Recurrence of hepatitis B after liver transplantation: Does hepatitis B immunoglobulin modify the recurrent disease? Transplant Proc 1990; 22:15491550. MEDLINE
  • 25
    Rimoldi P, Belli L, Rondinara G, Alberti A, DeCarlis L, Minola E. Recurrent HBV/HDV infections under different immunoprophylaxis protocols. Transplant Proc 1993; 25:26752676. MEDLINE
  • 26
    Marcellin P, Samuel D, Loriot MA, Areias J, Bismuth H, Benhamou JP. Anti-viral effect of adenine arabinoside monophosphate (ara-Amp) in patients with recurrence of hepatitis B virus (HBV) infection after liver transplantation [abstr]. Hepatology 1990; 12:966A.
  • 27
    Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, et al. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg 1996; 2:132138. MEDLINE
  • 28
    Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, et al. An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: Anti-viral effects and risk of rejection. Hepatology 1995; 22:10841089. MEDLINE
  • 29
    Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B–related end-stage liver disease. Hepatology 1994; 19:612. MEDLINE
  • 30
    Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B virus infection. N Engl J Med 1995; 333:16571661. MEDLINE
  • 31
    Perrillo RP, Rakela J, Martin P, Levy GL, Schiff ER, Wright T, et al. Lamivudine for hepatitis B after liver transplantation. Hepatology 1996; 24:182A.
  • 32
    Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24:711713. MEDLINE
  • 33
    Wang Y, Bowden DS, Shaw T, Civitico G, Chan Y, Qiao M, et al. Inhibition of duck hepatitis B virus replication in vivo by the nucleoside analogue ganciclovir. Antiviral Chem Chemother 1991; 2:107114.
  • 34
    Chossegros P, Pouteil-Noble C, Samuel D, Causse X, Ouzan D, Bizollon T, et al. Ganciclovir is an effective anti-viral agent for post-transplantation chronic HBV infections, maintenance therapy may be required in some cases [abstr]. Gastroenterology 1993; 104:A888.
  • 35
    De la Mata M, Montero JL, Fraga E, Costan G, Delgado M, Lopez R, et al. Efficacy of ganciclovir in the treatment of hepatitis B virus infection of the liver graft. Long-term results [abstr]. Hepatology 1995; 22:130A.